Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Perri

Showing results (21-30 of 229) with videos related to

Pageof 23
Sort By:
Journal of Clinical Medicine|March 28, 2026
Beyond Visual Inspection: A Systematic Review of Adjunctive Aids for the Early Detection of Oral Squamous Cell CarcinomaPetra Claudia Camilla D'Orsi, Saman Warnakulasuriya, Francesco Perri, et al.
European Journal of Human Genetics : EJHG|August 27, 2003
Mutation analysis of the cystic fibrosis transmembrane conductance regulator (CFTR) gene, the cationic trypsinogen (PRSS1) gene, and the serine protease inhibitor, Kazal type 1 (SPINK1) gene in patients with alcoholic chronic pancreatitisFrancesco Perri, Ada Piepoli, Pietro Stanziale, et al.
European Journal of Gastroenterology & Hepatology|November 14, 2007
Artificial neural networks can classify uninvestigated patients with dyspepsiaAngelo Andriulli, Enzo Grossi, Massimo Buscema, et al.
Helicobacter|April 23, 2002
Amoxicillin/tetracycline combinations are inadequate as alternative therapies for Helicobacter pylori infectionFrancesco Perri, Virginia Festa, Antonio Merla, et al.
World Journal of Gastrointestinal Oncology|December 17, 2010
Role of interleukin polymorphisms in gastric cancer: "Pros and cons"Francesco Perri, Fulvia Terracciano, Marco Gentile, et al.
Clinical Case Reports|January 25, 2021
New-generation anticancer drugs and medication-related osteonecrosis of the jaw (MRONJ): Late onset 3 years after ipilimumab endovenous administration with a possible role of target therapyAgostino Guida, Francesco Perri, Franco Ionna, et al.
World Journal of Clinical Oncology|December 16, 2011
Locally advanced nasopharyngeal carcinoma: Current and emerging treatment strategiesFrancesco Perri, Davide Bosso, Carlo Buonerba, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 25, 2010
Long-term outcome after antiviral therapy of patients with hepatitis C virus infection and decompensated cirrhosisAngelo Iacobellis, Francesco Perri, Maria Rosa Valvano, et al.
Journal of Clinical Medicine|January 21, 2023
Survival and Toxicities of Metastatic Colorectal Cancer Patients Treated with Regorafenib before TAS-102 or Vice Versa: A Mono-Institutional Real-Practice StudyAlessandro Ottaiano, Mariachiara Santorsola, Francesco Perri, et al.
Artificial Intelligence in Medicine|August 22, 2006
Selection of relevant genes in cancer diagnosis based on their prediction accuracyRosalia Maglietta, Annarita D'Addabbo, Ada Piepoli, et al.
Pageof 23

Showing results (21-30 of 229) with videos related to

Sort By:
Pageof 23
Journal of Clinical Medicine|March 28, 2026
Beyond Visual Inspection: A Systematic Review of Adjunctive Aids for the Early Detection of Oral Squamous Cell CarcinomaPetra Claudia Camilla D'Orsi, Saman Warnakulasuriya, Francesco Perri, et al.
European Journal of Human Genetics : EJHG|August 27, 2003
Mutation analysis of the cystic fibrosis transmembrane conductance regulator (CFTR) gene, the cationic trypsinogen (PRSS1) gene, and the serine protease inhibitor, Kazal type 1 (SPINK1) gene in patients with alcoholic chronic pancreatitisFrancesco Perri, Ada Piepoli, Pietro Stanziale, et al.
European Journal of Gastroenterology & Hepatology|November 14, 2007
Artificial neural networks can classify uninvestigated patients with dyspepsiaAngelo Andriulli, Enzo Grossi, Massimo Buscema, et al.
Helicobacter|April 23, 2002
Amoxicillin/tetracycline combinations are inadequate as alternative therapies for Helicobacter pylori infectionFrancesco Perri, Virginia Festa, Antonio Merla, et al.
World Journal of Gastrointestinal Oncology|December 17, 2010
Role of interleukin polymorphisms in gastric cancer: "Pros and cons"Francesco Perri, Fulvia Terracciano, Marco Gentile, et al.
Clinical Case Reports|January 25, 2021
New-generation anticancer drugs and medication-related osteonecrosis of the jaw (MRONJ): Late onset 3 years after ipilimumab endovenous administration with a possible role of target therapyAgostino Guida, Francesco Perri, Franco Ionna, et al.
World Journal of Clinical Oncology|December 16, 2011
Locally advanced nasopharyngeal carcinoma: Current and emerging treatment strategiesFrancesco Perri, Davide Bosso, Carlo Buonerba, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 25, 2010
Long-term outcome after antiviral therapy of patients with hepatitis C virus infection and decompensated cirrhosisAngelo Iacobellis, Francesco Perri, Maria Rosa Valvano, et al.
Journal of Clinical Medicine|January 21, 2023
Survival and Toxicities of Metastatic Colorectal Cancer Patients Treated with Regorafenib before TAS-102 or Vice Versa: A Mono-Institutional Real-Practice StudyAlessandro Ottaiano, Mariachiara Santorsola, Francesco Perri, et al.
Artificial Intelligence in Medicine|August 22, 2006
Selection of relevant genes in cancer diagnosis based on their prediction accuracyRosalia Maglietta, Annarita D'Addabbo, Ada Piepoli, et al.
Pageof 23